Reza Shahriarirad

Dr. Reza Shahriarirad

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Virology Journal
Verified
Journal Article
Open access
PDF file
GSGolnar Sabetian
Golnar Sabetian
MMMohsen Moghadami
Mohsen Moghadami
LHLeila Hashemizadeh Fard Haghighi
Leila Hashemizadeh Fard Haghighi
RSReza Shahriarirad
Reza Shahriarirad
MFMohammad Javad Fallahi
Mohammad Javad Fallahi
YMYalda Sadat Moeini
Yalda Sadat Moeini
Objective: With the novel coronavirus pandemic, the impact on the healthcare system and workers cannot be overlooked. However, studies on the infection status of medical personnel are still lacking. It is imperative to ensure the safety of health-care workers (HCWs) not only to safeguard continuous patient care but also to ensure they do not transmit the virus, therefore evaluation of infection rates in these groups are indicated. Methods: Demographic and clinical data regarding infected cases among HCWs of Fars, Iran with positive SARS‐CoV‐2 PCR tests were obtained from 10th March to 17th May 2020. Results: Our data demonstrated a rate of 5.62% (273 out of 4854 cases) infection among HCW, with a mean age of 35 years and a dominance of female cases (146 cases: 53.5%). The majority of infected cases were among nurses (51.3%), while the most case infection rate (CIR) was among physicians (27 positive cases out of 842 performed test (3.2%)). Also, the highest rate of infection was in the emergency rooms (30.6%). Also, 35.5% of the patients were asymptomatic and the most frequent clinical features among symptomatic patients were myalgia (46%) and cough (45.5%). Although 5.5% were admitted to hospitals, there were no reports of ICU admission. Furthermore, 10.3% of the cases reported transmitting the infection to family and friends. Regarding safety precautions, 1.6% didn't wear masks and 18.7% didn't use gloves in work environments. Conclusion: HCWs are among the highest groups at risk of infection during the COVID-19 pandemic; therefore, evaluating infection rates and associated features is necessary to improve and adjust protective measures of these vulnerable, yet highly essential group.

12 January 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MZMojtaba Zare
Mojtaba Zare
HAHossein Akbarialiabad
Hossein Akbarialiabad
HPHossein Parsaei
Hossein Parsaei
QAQasem Asgari
Qasem Asgari
AAAli Alinejad
Ali Alinejad
GAGholamreza Abdollahifard
Gholamreza Abdollahifard
Background: Leishmaniasis, a disease caused by a protozoan, causes numerous deaths in humans each year. After malaria, leishmaniasis is known to be the deadliest parasitic disease globally. Direct visual detection of leishmania parasite through microscopy is the frequent method for diagnosis of this disease. However, this method is time-consuming and subject to errors. This study was aimed to develop an artificial intelligence-based algorithm for automatic diagnosis of leishmaniasis. Methods: We used the Viola-Jones algorithm to develop a leishmania parasite detection system. The algorithm includes three procedures: feature extraction, integral image creation, and classification. Haar-like features are used as features. An integral image was used to represent an abstract of the image that significantly speeds up the algorithm. The adaBoost technique was used to select the discriminate features and to train the classifier. Results: A 65% recall and 50% precision was concluded in the detection of macrophages infected with the leishmania parasite. Also, these numbers were 52% and 71%, respectively, related to amastigotes outside of macrophages. Conclusion: The developed system is accurate, fast, easy to use, and cost-effective. Therefore, artificial intelligence might be used as an alternative for the current leishmanial diagnosis methods.

13 July 2021 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
AEAlireza Ebrahimi
Alireza Ebrahimi
HAHanie Ahmadi
Hanie Ahmadi
ZGZahra Pourfraidon Ghasrodashti
Zahra Pourfraidon Ghasrodashti
NTNader Tanide
Nader Tanide
RSReza Shahriarirad
Reza Shahriarirad
SESoheil Ashkani Esfahani
Soheil Ashkani Esfahani
Stem cell therapy has been used to treat several types of diseases, and it is expected that its therapeutic uses shall increase as novel lines of evidence begin to appear. Furthermore, stem cells have the potential to make new tissues and organs. Thus, some scientists propose that organ transplantation will significantly rely on stem cell technology and organogenesis in the future. Stem cells and its robust potential to differentiate into specific types of cells and regenerate tissues and body organs, have been investigated by numerous clinician scientists and researchers for their therapeutic effects. Degenerative diseases in different organs have been the main target of stem cell therapy. Neurodegenerative diseases such as Alzheimer's, musculoskeletal diseases such as osteoarthritis, congenital cardiovascular diseases, and blood cell diseases such as leukemia are among the health conditions that have benefited from stem cell therapy advancements. One of the most challenging parts of the process of incorporating stem cells into clinical practice is controlling their division and differentiation potentials. Sometimes, their potential for uncontrolled growth will make these cells tumorigenic. Another caveat in this process is the ability to control the differentiation process. While stem cells can easily differentiate into a wide variety of cells, a paracrine effect controlled activity, being in an appropriate medium will cause abnormal differentiation leading to treatment failure. In this review, we aim to provide an overview of the therapeutic effects of stem cells in diseases of various organ systems. In order to advance this new treatment to its full potential, researchers should focus on establishing methods to control the differentiation process, while policymakers should take an active role in providing adequate facilities and equipment for these projects. Large population clinical trials are a necessary tool that will help build trust in this method. Moreover, improving social awareness about the advantages and adverse effects of stem cell therapy is required to develop a rational demand in the society, and consequently, healthcare systems should consider established stem cell-based therapeutic methods in their treatment algorithms.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FRFahimeh Rezazadeh
Fahimeh Rezazadeh
FFFarzane Farahmand
Farzane Farahmand
HHHamidreza Hosseinpour
Hamidreza Hosseinpour
RSReza Shahriarirad
Reza Shahriarirad
AEAmirhasan Sabet Eghlidi
Amirhasan Sabet Eghlidi
Introduction. Burning mouth syndrome (BMS) is one of the challenging clinical problems not only in its diagnosis and treatment but also its concurring mental impact. This study is aimed at determining the association between psychological factors, including emotional stress, depression, anxiety, and sleep pattern among BMS patients. Methods. In this cross‐sectional study, 19 patients with idiopathic BMS were enrolled along with a control group equivalent in age and sex, but without BMS. Questionnaires used were the Visual Analog Scale (VAS), the Pittsburgh Sleep Quality Index (PSQI), and the Depression, Anxiety, and Stress Scale (DASS‐21). Demographic information was also recorded and analyzed. Results. There was a significant correlation among the two groups of BMS and non‐BMS patients regarding stress, depression, and sleep disorder. The average severity of the burning score was 8.31 among the patients. Furthermore, a significant correlation was observed among mental disorders and educational level and sex, but not with age. There was also no significant correlation among the severity of the burning score with sex, education, and mental disorder. Conclusion. BMS is significantly associated with psychological symptoms. This condition requires proper treatment and support because it can represent psychological or mental issues and/or have a significant effect on daily life.

22 November 2021 in Virology Journal
Verified
Journal Article
Open access
PDF file
MSMojtaba Shafiekhani
Mojtaba Shafiekhani
FSFarbod Shahabinezhad
Farbod Shahabinezhad
TNTahmoores Niknam
Tahmoores Niknam
STSeyed Ahmad Tara
Seyed Ahmad Tara
EHElham Haem
Elham Haem
SMSeyed Ali Malekhosseini
Seyed Ali Malekhosseini
Background: The management of COVID-19 in organ transplant recipients is among the most imperative, yet less discussed, issues based on their immunocompromised status along with their vast post-transplant medication regimens. No conclusive study has been published to evaluate proper anti-viral and immunomodulator medications effect in treating COVID-19 patients to this date. Method: This retrospective study was conducted in Shiraz Transplant Hospital, Iran from March 2020 to May 2021 and included COVID-19 diagnosed patients based on SARS-CoV-2 RT-PCR positive test who had been hospitalized for at least 48 h before enrolling in the study. Clinical and demographic information of patients, along with their treatment course and the medication used were evaluated and analyzed using multiple regression analysis. Results: A total of 245 patients with a mean age of 49.59 years were included with a mortality rate of 8.16%. The administration of Remdesivir as an anti-viral drug (P value < 0.001) and Tocilizumab as an immunomodulator drug (P value < 0.001) could reduce the hospitalization period in the hospital and the intensive care unit, as well as the mortality rates significantly. Meanwhile, the patients treated with Lopinavir/Ritonavir experienced a lower chance of survival (OR < 1, P value = 0.04). No significant difference was observed between various therapeutic regimens in clinical complications such as bacterial coinfections, cardiovascular and gastrointestinal adverse reactions, and liver or kidney dysfunctions. Conclusion: The administration of Remdesivir as an anti-viral and Tocilizumab as an immunomodulatory drug in solid-organ transplant recipients could be promising treatments of choice to manage COVID-19.

1 August 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
AKAbdolkhalegh Keshavarzi
Abdolkhalegh Keshavarzi
HMHashem Montaseri
Hashem Montaseri
RARahimeh Akrami
Rahimeh Akrami
HSHossein Moradi Sarvestani
Hossein Moradi Sarvestani
FKFateme Khosravi
Fateme Khosravi
RSReza Shahriarirad
Reza Shahriarirad
Background. Great plantain (Plantago major L. or P.major) is a medicinal plant that is available all around the world. The whole plant has several bioactive compounds including terpenoids, flavonoids, phenolic compounds, alkaloids, fatty acids, iridoid glycosides, polysaccharides, and vitamins. Scientific studies have recognized several medical benefits like wound healing, anti‐inflammatory, antimicrobial, antiulcerative, and antioxidative agents. The wound‐healing capacity of this plant has been investigated under in vivo and ex vivo conditions. In the current study, we aim to compare the therapeutic effect of the P.major extract with 1% sulfadiazine on the healing of second‐degree burn wounds. Method. Second‐degree burn victims were included in our study. The investigation and control group, respectively, received P. major ointment 10% and silver sulfadiazine ointment 1%. The bacterial culture from the wound site was taken on days 3, 7, 10, 13, and last day of hospitalization. Patients’ subjective complaints were obtained through the visual analog scale (VAS). All patients were treated and evaluated in the hospital. Result. Among the 15 patients, 11 were male, and the mean age was 33.3 years. The average complete healing duration was 11.73 vs. 13 days in the P. major and control group, respectively (P = 0.166). On the third day, infection control was similar between the two groups, and on the seventh day, all bacterial cultures were negative. Although there was a significant reduction in pain scores during the recovery time, no significant differences in pain reduction were noted between the two groups (P = 0.849). Conclusion. We showed that P.major ointment is a safe and suitable herbal compound in the treatment of second‐degree burn wounds that not only has wound‐healing properties but also is an analgesic and antimicrobial compound.